Trials / Completed
CompletedNCT03131583
The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout
A Phase I, Single-Center, Open-Label, Single-Group Study to Evaluate Potential Pharmacodynamics of Drug-Drug Interaction Between SHR4640 and Febuxostat and Between SHR4640 and Colchicine in Patients With Gout
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640, Febuxostat and Colchicine interaction in patients with gout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colchicine | Day-14\~Day16 qd |
| DRUG | Febuxostat | Day1 and Day8 qd |
| DRUG | SHR4640 | Day3\~Day8 qd |
Timeline
- Start date
- 2017-02-17
- Primary completion
- 2018-01-29
- Completion
- 2018-01-29
- First posted
- 2017-04-27
- Last updated
- 2019-08-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03131583. Inclusion in this directory is not an endorsement.